Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
446.54
+3.38 (+0.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
72
73
Next >
3 Stocks That Could Trounce the Market in 2025
↗
February 17, 2025
Via
The Motley Fool
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
↗
February 15, 2025
Via
The Motley Fool
The Ultimate Healthcare Stock to Buy With $500 Right Now
↗
February 14, 2025
Via
The Motley Fool
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
↗
February 14, 2025
Via
The Motley Fool
Moderna (MRNA) Q4 Earnings Report Preview: What To Look For
February 13, 2025
Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market open. Here’s what to expect.
Via
StockStory
Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday
↗
February 12, 2025
Via
The Motley Fool
Vertex Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results
↗
February 11, 2025
Via
Benzinga
Vertex: Strong Sales, Stronger Pipeline
↗
February 11, 2025
Via
The Motley Fool
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
↗
February 04, 2025
Via
Benzinga
This NXP Semiconductors Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
↗
February 12, 2025
Via
Benzinga
Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.
↗
February 11, 2025
The company is entering a year of commercial launches. Those aren't guaranteed to put up cystic fibrosis-like numbers.
Via
Investor's Business Daily
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
February 11, 2025
Biotech company Biogen (NASDAQ:BIIB) will be announcing earnings results tomorrow morning. Here’s what to look for.
Via
StockStory
Vertex Pharma Stock Flooded With Price-Target Hikes After Upbeat Q4 Revenue, 2025 Outlook: Retail Stays Bullish
↗
February 11, 2025
The company is betting on strong sales of its cystic fibrosis drugs and early traction from its newly approved non-opioid painkiller.
Via
Stocktwits
Markets Steady, Positive; Q4 Earnings Keep Rolling
↗
February 10, 2025
Markets were flat but positive in an initial trading day for a new week, basically shrugging off whatever warning signs may have been considered regarding President Trump’s 25% steel tariff headline...
Via
Talk Markets
Topics
Government
Stocks / Equities
World Trade
Vertex Pharmaceuticals Unusual Options Activity
↗
February 03, 2025
Via
Benzinga
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript
↗
February 10, 2025
VRTX earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Vertex's Revenue Surges but EPS Slips
↗
February 10, 2025
The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.
Via
The Motley Fool
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 Sales Top Estimates
February 10, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 15.7% year on year to $2.91 billion. The company expects the...
Via
StockStory
Vertex Reports Fourth Quarter and Full Year 2024 Financial Results
February 10, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?
↗
February 10, 2025
Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth potential. Stock has bullish technicals but risks remain.
Via
Benzinga
Top Wall Street Forecasters Revamp Vertex Pharmaceuticals Price Expectations Ahead Of Q4 Earnings
↗
February 10, 2025
Via
Benzinga
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst
↗
February 10, 2025
U.S. stock futures rose on Monday following Friday's sharp fall as investors digest tariff updates and earnings reports.
Via
Benzinga
Topics
World Trade
McDonald's, ON Semiconductor And 3 Stocks To Watch Heading Into Monday
↗
February 10, 2025
Stock futures up, focus on McDonald's, ON Semiconductor, VOXX, Rockwell Automation, Vertex Pharmaceuticals.
Via
Benzinga
2 Biotech Stocks to Buy Hand Over Fist in February
↗
February 09, 2025
Via
The Motley Fool
Earnings Scheduled For February 10, 2025
↗
February 10, 2025
Via
Benzinga
Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For
February 09, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for.
Via
StockStory
UnitedHealth, Vertex Pharmaceuticals, Axon Enterprise And A Major Energy Stock: CNBC's 'Final Trades'
↗
February 06, 2025
UnitedHealth reported fourth-quarter adjusted EPS of $6.81, up from $6.16 a year ago, beating the consensus of $6.72.
Via
Benzinga
Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?
↗
February 04, 2025
Via
The Motley Fool
3 Magnificent Stocks to Buy and Hold Forever
↗
February 03, 2025
Via
The Motley Fool
Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
↗
February 02, 2025
Via
The Motley Fool
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
